This company listing is no longer active
Silk Road Medical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Chas McKhann
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 3.6yrs |
| Board average tenure | 5.9yrs |
Recent management updates
Recent updates
CEO
Chas McKhann (54 yo)
less than a year
Tenure
Mr. Charles S. McKhann, also known as Chas, serves as Chief Executive Officer at Silk Road Medical, Inc since November 02, 2023. He serves as President, Chief Executive Officer and Director at Apollo Endos...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CFO & COO | 7.6yrs | US$9.56m | 0.36% € 2.2m | |
| EVP, Chief Legal Officer & Secretary | 1.5yrs | US$2.64m | 0.0091% € 57.1k | |
| Chief Commercial Officer | 3.6yrs | US$7.90m | 0.14% € 887.4k | |
| Executive Vice President of Clinical | no data | US$1.50m | 0.30% € 1.9m | |
| Chief Executive Officer | less than a year | no data | no data | |
| Chief Accounting Officer & VP of Finance | 6yrs | no data | 0.12% € 763.5k | |
| Compliance Officer & VP of Medical Affairs | 2.1yrs | no data | no data | |
| Vice President of Human Resources | no data | no data | no data | |
| Executive Medical Director | 4.9yrs | no data | no data | |
| Investors Relations Officer | no data | no data | no data |
3.6yrs
Average Tenure
54yo
Average Age
Experienced Management: 2OW's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman | 16.8yrs | US$226.80k | 0.016% € 99.7k | |
| Independent Director | 10.8yrs | US$174.97k | 0.37% € 2.3m | |
| Independent Director | 5.9yrs | US$192.97k | 0.0053% € 33.2k | |
| Independent Director | 3.3yrs | US$184.97k | 0.0036% € 22.9k | |
| Independent Director | 16.9yrs | US$164.97k | 0.19% € 1.2m | |
| Independent Director | 2.6yrs | US$166.29k | 0.0022% € 13.6k | |
| Independent Director | 3.2yrs | US$184.63k | 0.0036% € 22.9k |
5.9yrs
Average Tenure
62yo
Average Age
Experienced Board: 2OW's board of directors are considered experienced (5.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/28 17:39 |
| End of Day Share Price | 2023/12/01 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Silk Road Medical, Inc is covered by 9 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Argus Research Company |
| Joanne Wuensch | BMO Capital Markets Equity Research |
| Travis Steed | BofA Global Research |